SRPT 8-K 2026-07-27

Sarepta Therapeutics, Inc. (SRPT) 8-K dated 2026-07-27 — accession 0001193125-26-316995. This URL is the filing, not the SRPT hub.

Sarepta Therapeutics, Inc. (SRPT) is a biotechnology company listed on US.

Sarepta Therapeutics, Inc. filed a 8-K on 2026-07-27. Accession 0001193125-26-316995.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.

Not investment advice. The SRPT SEC hub lists recent forms. The stock page is the research view.